Viability does not necessarily reflect the hematopoietic progenitor cell potency of a cord blood unit: Results of an interlaboratory exercise

Transfusion

Volumn 48, Issue 3, 2008, Pages 546-549

  Brand, Anneke ^a   Eichler, Hermann ^b   Szczepiorkowski, Zbigniew M ^b   Hess, John R ^b   Kekomaki, Riitta ^b   McKenna, David H ^b   Pamphilon, Derwood ^b   Reems, JoAnna ^b   Sacher, Ronald A ^b   Takahashi, Tsuneo A ^b   Van De Watering, Leo M G ^b  

^a Leiden Cord Bloodbank Sanquin   (Netherlands)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CD34 SELECTION; CELL VIABILITY; CORD BLOOD STEM CELL TRANSPLANTATION; CRYOPRESERVATION; FLOW CYTOMETRY; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; LABORATORY; THAWING;

ANTIGENS, CD34; BLOOD BANKS; BLOOD TRANSFUSION; CELL COUNT; CELL SURVIVAL; FETAL BLOOD; HEMATOLOGY; HEMATOPOIETIC STEM CELLS; HUMANS; LABORATORIES;

EID: 39749143957     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2007.01568.x     Document Type: Article

References (11)

1. Rubinstein P, Carrier C, Scaradavou A, Kurtzberg J, Adamson J, Migliaccio AR, Berkowitz RL, Cabbad M, Dobrila NL, Taylor PE, Rosenfield RE, Stevens CE. Outcome among 562 recipients of placental-blood transplants from unrelated donors. N Engl J Med 1998 339 : 1565 77.
2. Migliaccio AR, Adamson JW, Stevens CE, Dobrila Nela L, Carrier C, Rubinstein P. Cell dose and speed of engraftment in placental/umbilical cord blood transplantation: graft progenitor cell content is a better predictor than nucleated cell quantity. Blood 2000 96 : 2717 22.
3. Wagner JE, Barker JN, DeFor TE, Baker KS, Blazar BR, Goldman A, Kersey J, Krivit W, MacMillan M, Orchard P, Peters C, Weisdorf D, Ramsay NKC, Davies SM. Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity and treatment-related mortality and survival. Blood 2002 100 : 1611 8.
4. Long GD, Laughlin M, Madan B, Kurtzberg J, Gasparetto C, Morris A, Rizzieri D, Smith C, Vredenburgh J, Halperin EC, Broadwater G, Niedzwiecki D, Chao NJ. Unrelated umbilical cord blood transplantation in adult patients. Biol Blood Marrow Transplant 2003 9 : 772 80.
5. Rogers I, Sutherland DR, Holt D, Macpate F, Lains A, Hollowell S, Cruickshank B, Casper RF. Human UC-blood banking: impact of blood volume, cell separation and cryopreservation on leukocyte and CD34+ recovery. Cytotherapy 2001 3 : 269 76.
6. Laroche V, McKenna DH, Moroff G, Schierman T, Kadidlo D, McCullough J. Cell loss and recovery in umbilical cord blood processing: a comparison of post-thaw and post-wash samples. Transfusion 2005 45 : 1909 16.
7. Van Haute I, Lootens N, De Smet S, De Buck C, Verdegem L, Vanheusden K, Pinxteren J, Vandekerckhove B. Viable CD34+ stem cell content of a cord blood graft: which measurement performed before transplantation is most representative? Transfusion 2004 44 : 547 54.
8. Rubinstein P, Dobrila L, Rosenfield RE, Adamson JW, Migliaccio G, Migliaccio AR, Taylor PE, Stevens CE. Processing and cryopreservation of placental/umbilical cord blood for unrelated bone marrow reconstruction. Proc Natl Acad Sci U S A 1995 92 : 1019 22.
9. Xiao M, Dooley DC. Assessment of cell viability and apoptosis in human umbilical cord blood following storage. J Hematother Stem Cell Res 2003 12 : 115 22.
10. Barnett D, Granger V, Kraan J, Whitby L, Reilly JT, Papa S, Gratama JW. Reduction of intra- and interlaboratory variation in CD34+ stem cell enumeration using stable test material, standard protocols and targeting training. Br J Haematol 2000 108 : 784 92.
11. de Boer F, Dräger AM, Pinedo HM, Kessler FL, Monnee-van Muijen M, Weijers Westra G, van der Wall E, Netelenbos T, Oberink JW, Huijgens PC, Schuurhuis GJ. Early apoptosis largely accounts for functional impairment of CD34+ cells in frozen-thawed stem cell grafts. J Hematother Stem Cell Res 2002 11 : 951 63.